asa statement on glp 1 Perioperative management of patients taking glucagon-like peptide-1 receptor agonists: a restrictive fasting regimen is not necessary. Comment Br J Anaesth 2025; 135: 48–78 Aspiration risk tops anesthesiologists' concerns
Description
10.1016/S2213-8587(21)00179-0 60 NicholsG
Semaglutide, marketed as Ozempic, Wegovy, and Rybelsus, is an FDA-approved GLP-1 receptor agonist used for type 2 diabetes and chronic weight management
I was able to get pharmacy information via the support channels, though it took effort
Bariatric Surgery versus Intensive Medical Therapy for Diabetes 5-Year Outcomes
